<DOC>
	<DOCNO>NCT00829634</DOCNO>
	<brief_summary>The intent study see rate body break l-methamphetamine ( l-MA ) could use accurate estimate rate body break d-methamphetamine ( d-MA ) . l-MA sold counter nasal decongestant d-MA commonly abuse form methamphetamine .</brief_summary>
	<brief_title>Steady State Kinetics l-Methamphetamine Validation Sensitivity Dose Estimation</brief_title>
	<detailed_description>Subjects screen St. Luke 's Hospital San Francisco determine eligibility . Once enrolled study take two week . During first week subject attend daily , hour-long outpatient visit San Francisco General Hospital . At visit subject receive oral dose l-methamphetamine , vitals read , answer questionnaire receive blood draw . During second week study subject admit San Francisco General Hospital week long inpatient stay . During stay subject continue receive l-methamphetamine also receive three dos d-methamphetamine three separate day . In addition subject receive blood draw , urine collect , answer questionnaire .</detailed_description>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>Healthy Males Females Between Ages 18 50 Must experience methamphetamine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>methamphetamine</keyword>
	<keyword>inpatient</keyword>
	<keyword>d-MA</keyword>
	<keyword>l-MA</keyword>
	<keyword>APRL</keyword>
	<keyword>San Francisco</keyword>
	<keyword>metabolism</keyword>
	<keyword>Metabolism methamphetamine</keyword>
</DOC>